Literature DB >> 30282821

Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.

Masaaki Yamamoto1, Anat Ben-Shlomo1, Hiraku Kameda1, Hidenori Fukuoka1, Nan Deng2, Yan Ding1, Shlomo Melmed1.   

Abstract

Pituitary corticotroph somatostatin receptor subtype 5 (SSTR5) signals to inhibit adrenocorticotrophin (ACTH) secretion. As ACTH deficiency results in attenuated adrenal cortisol production and an impaired stress response, we sought to clarify the role of SSTR5 in modifying the hypothalamic/pituitary/adrenal (HPA) axis. We generated Tg HP5 mice overexpressing SSTR5 in pituitary corticotrophs that produce the ACTH precursor proopiomelanocortin (POMC). Basal ACTH and corticosterone were similar in HP5 and WT mice, while HP5 mice showed attenuated ACTH and corticosterone responses to corticotrophin releasing hormone (CRH). HP5 mice exhibited attenuated corticosterone responses upon a restraint stress test and inflammatory stress following LPS injection, as well as increased anxiety-like and depressive-like behavior on open field and forced swim tests. Pituitary corticotroph CRH receptor subtype 1 (CRHR1) mRNA expression and ACTH responses to CRH were also attenuated in HP5 mice. In AtT20 cells stably overexpressing SSTR5, CRHR1 expression and cAMP response to CRH were reduced, whereas both were increased after SSTR5 KO. In elucidating mechanisms for these observations, we show that SSTR5-induced miR-449c suppresses both CRHR1 expression and function. We conclude that corticotroph SSTR5 attenuates HPA axis responses via CRHR1 downregulation, suggesting a role for SSTR5 in the pathogenesis of secondary adrenal insufficiency.

Entities:  

Keywords:  Endocrinology; Neuroendocrine regulation; growth factors

Year:  2018        PMID: 30282821      PMCID: PMC6237446          DOI: 10.1172/jci.insight.122932

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  64 in total

1.  The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

Authors:  Leo J Hofland; Joost van der Hoek; Richard Feelders; Maarten O van Aken; Peter M van Koetsveld; Marlijn Waaijers; Diana Sprij-Mooij; Christian Bruns; Gisbert Weckbecker; Wouter W de Herder; Albert Beckers; Steven W J Lamberts
Journal:  Eur J Endocrinol       Date:  2005-04       Impact factor: 6.664

2.  Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice.

Authors:  Michael L Seibenhener; Michael C Wooten
Journal:  J Vis Exp       Date:  2015-02-06       Impact factor: 1.355

3.  A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells.

Authors:  David Langlais; Catherine Couture; Guillaume Sylvain-Drolet; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2010-12-30

4.  Pituitary-specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice.

Authors:  G D Hammer; V Fairchild-Huntress; M J Low
Journal:  Mol Endocrinol       Date:  1990-11

5.  Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin.

Authors:  J Kraicer; T C Gajewski; B C Moor
Journal:  Neuroendocrinology       Date:  1985-11       Impact factor: 4.914

6.  Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

Authors:  M P Stenzel-Poore; S C Heinrichs; S Rivest; G F Koob; W W Vale
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

7.  Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

Authors:  G W Smith; J M Aubry; F Dellu; A Contarino; L M Bilezikjian; L H Gold; R Chen; Y Marchuk; C Hauser; C A Bentley; P E Sawchenko; G F Koob; W Vale; K F Lee
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

Review 8.  Isolated acquired ACTH deficiency and primary hypothyroidism: a short series and review.

Authors:  M J Hannon; D J O'Halloran
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

9.  Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency.

Authors:  Anne-Marie Pulichino; Sophie Vallette-Kasic; Catherine Couture; Yves Gauthier; Thierry Brue; Michel David; Georges Malpuech; Cheri Deal; Guy Van Vliet; Monique De Vroede; Felix G Riepe; Carl-Joachim Partsch; Wolfgang G Sippell; Merih Berberoglu; Begüm Atasay; Jacques Drouin
Journal:  Genes Dev       Date:  2003-03-15       Impact factor: 11.361

10.  Constitutive somatostatin receptor subtype-3 signaling suppresses growth hormone synthesis.

Authors:  Tamar Eigler; Anat Ben-Shlomo; Cuiqi Zhou; Ramtin Khalafi; Song-Guang Ren; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2014-02-25
View more
  3 in total

Review 1.  The Mechanisms Underlying Autonomous Adrenocorticotropic Hormone Secretion in Cushing's Disease.

Authors:  Hidenori Fukuoka; Hiroki Shichi; Masaaki Yamamoto; Yutaka Takahashi
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 2.  Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System.

Authors:  Bilal Haider Shamsi; Mahanand Chatoo; Xiao Kang Xu; Xun Xu; Xue Qun Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

3.  Potential of microRNA expression profile in predicting renal impairment risk in multiple myeloma patients.

Authors:  Daijin Ren; Yuwen Cai; Gaosi Xu
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.